Affiliated Hospital of Yunnan University
7
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
Role: collaborator
Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome
Role: collaborator
Research on Three-level Prevention and Intervention for Elderly Depression in Urban Community
Role: lead
Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis
Role: collaborator
A Clinical Study of the Effects of Environmental Pollution on Obesity
Role: collaborator
A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults
Role: lead
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
Role: collaborator
All 7 trials loaded